reviewJAMAApr 1, 2003Closed access

Statin-Associated Myopathy

PDPaul D. ThompsonPMPriscilla M. ClarksonRHRichard H. Karas

Hartford Hospital · Hartford Financial Services (United States)

PubMed
Indexed incrossrefpubmed

Abstract

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are associated with skeletal muscle complaints, including clinically important myositis and rhabdomyolysis, mild serum creatine kinase (CK) elevations, myalgia with and without elevated CK levels, muscle weakness, muscle cramps, and persistent myalgia and CK elevations after statin withdrawal. We performed a literature review to provide a clinical summary of statin-associated myopathy and discuss possible mediating mechanisms. We also update the US Food and Drug Administration (FDA) reports on statin-associated rhabdomyolysis. Articles on statin myopathy were identified via a PubMed search through November 2002 and articles on statin clinical…

Citation impact

1,448
total citations
FWCI
97.50
Percentile
100%
References
118
Citations per year

Authors

3

Topics & keywords

Keywords
  • Medicine
  • Rhabdomyolysis
  • myalgia
  • Statin
  • Myopathy
  • Cerivastatin
  • Adverse effect
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.